Skip to main content
. 2016 Apr 23;389:839–849. doi: 10.1007/s00210-016-1245-3

Table 3.

The effect of EMD 386088 administration on 5-HT and its metabolite concentration and 5-HT metabolism in rat brain structures

Treatment (mg/kg) 5-HT (ng/g t) 5-HIAA (ng/g t) [5-HIAA]/[5-HT]
Hippocampus
 Vehicle 0 275 ± 11 168 ± 15 61 ± 5
 EMD386088 2.5 294 ± 11 185 ± 9 63 ± 2
5 288 ± 11 173 ± 15 59 ± 4
F(2, 21) = 0.79
NS
F(2, 21) = 0.44
NS
F(2, 21) = 0.22
NS
Nucleus accumbens
 Vehicle 0 481 ± 42 324 ± 21 69 ± 5
 EMD386088 2.5 551 ± 16 354 ± 14 64 ± 3
5 435 ± 31 298 ± 20 69 ± 3
F(2, 21) = 3.44
NS
F(2, 21) = 2.17
NS
F(2, 21) = 0.41
NS
Striatum
 Vehicle 0 369 ± 19 358 ± 22 97 ± 4
 EMD386088 2.5 381 ± 13 392 ± 16 103 ± 3
5 346 ± 18 352 ± 18 103 ± 6
F(2, 21) = 1.14
NS
F(2, 21) = 1.26
NS
F(2, 21) = 0.54
NS

EMD386088 was injected i.p. in a dose of 2.5 and 5 mg/kg; control group was treated i.p. with saline. The rats were decapitated about 30 min after drug injection. The results are expressed as the mean ± SEM (N = 8). The concentration of serotonin (5-HT) and its metabolite, 5-hydroxyindolacetic acid (5-HIAA), was expressed as ng/g tissue. The rate of 5-HT metabolism was expressed as the ratio [5-HIAA] / [5-HT] × 100. The indices were calculated using concentrations from individual tissue samples. The data were analyzed by means of one-way ANOVA, followed by Duncan’s post hoc test

NS not significant